Koninklijke Philips (PHG) to Issue Annual Dividend of $0.92 on May 9th

Koninklijke Philips (NYSE:PHG) announced an annual dividend on Wednesday, May 8th, Wall Street Journal reports. Stockholders of record on Friday, May 10th will be paid a dividend of 0.9154 per share by the technology company on Thursday, May 9th. This represents a dividend yield of 3.5%. The ex-dividend date is Thursday, May 9th.

Koninklijke Philips Price Performance

NYSE:PHG traded down $0.51 during mid-day trading on Wednesday, reaching $26.00. The stock had a trading volume of 1,016,553 shares, compared to its average volume of 1,190,669. The stock has a 50-day simple moving average of $21.35 and a two-hundred day simple moving average of $21.33. The stock has a market capitalization of $24.14 billion, a PE ratio of -27.61, a P/E/G ratio of 1.39 and a beta of 0.75. Koninklijke Philips has a 12 month low of $17.75 and a 12 month high of $29.44. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.20 and a quick ratio of 0.78.

Analysts Set New Price Targets

PHG has been the topic of several recent analyst reports. BNP Paribas upgraded shares of Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday. UBS Group raised Koninklijke Philips from a “sell” rating to a “neutral” rating in a research report on Tuesday, April 30th. JPMorgan Chase & Co. upgraded Koninklijke Philips from an “underweight” rating to a “neutral” rating in a research note on Tuesday, April 30th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a report on Thursday, February 8th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $19.00.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.